title: [Impact of cancer treatments on cognitive functions: the patients' view, their expectation and their interest in participating to cognitive rehabilitation workshops].
abstract: BACKGROUND
  Cancer and chemotherapy can have adverse effects on cognitive functions and quality of life of patients. We wanted to know the patients' view on these disorders, but also their expectations in terms of assessment and support.
  
  
  RESULTS
  A survey was conducted in day care hospital among 551 patients from three cancer centers. Most of the patients were between 40 and 74 years and suffered from breast cancer. Eighty-four percent were treated with chemotherapy. Forty-one percent of patients report memory problems, 26% were affected by specific concentration disorders, and 19% of the attention. On the whole, 52% of patients report at least one of the previous cognitive impairment. Among these patients, 80% evoked that the support of these problems was essential and 70% were willing to participate in "workshops" to deal with these disorders.
  
  
  CONCLUSIONS
  The cognitive impairment occurrence is a real problem for patients receiving chemotherapy and becomes a priority in the global management of their disease. Studies assessing a specific support of theses symptoms should be encouraged to help patients.
authors.affiliation: EA4700, université de Rouen, laboratoire PSY-NCA, rue Lavoisier, 76821 Mont-Saint-Aignan cedex, France. johan.lefel@chb.unicancer.fr
authors.forename: Johan
authors.initials: J
authors.lastname: Le Fel
authors.forename: Aurélie
authors.initials: A
authors.lastname: Daireaux
authors.forename: Sandrine
authors.initials: S
authors.lastname: Vandenbosshe
authors.forename: Natacha
authors.initials: N
authors.lastname: Heutte
authors.forename: Olivier
authors.initials: O
authors.lastname: Rigal
authors.forename: Katia
authors.initials: K
authors.lastname: Rovira
authors.forename: Florence
authors.initials: F
authors.lastname: Joly
authors.forename: Vincent
authors.initials: V
authors.lastname: Roy
mesh_terms: D000328:Adult; D000367:Age Factors; D000368:Aged; D000970:Antineoplastic Agents / Q000009:adverse effects*; D001288:Attention / Q000187:drug effects; D001530:Belgium; D001943:Breast Neoplasms / Q000188:drug therapy; D003071:Cognition / Q000187:drug effects*; D003072:Cognition Disorders / Q000139:chemically induced* / Q000523:psychology / Q000534:rehabilitation; D005260:Female; D005602:France; D006306:Health Surveys; D006801:Humans; D008297:Male; D008569:Memory Disorders / Q000139:chemically induced* / Q000523:psychology / Q000534:rehabilitation; D008875:Middle Aged; D009369:Neoplasms / Q000188:drug therapy*; D055815:Young Adult
chemical_list: D000970:Antineoplastic Agents
keywords: cancer; chemotherapy; cognitive disorders; rehabilitation